Search Results - "DIBRA, Denada"

Refine Results
  1. 1

    Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells by SATELLI, Arun, MITRA, Abhisek, LUDWIG, Joseph A, KLEINERMAN, Eugenie S, SHULIN LI, CUTRERA, Jeffry J, DEVARIE, Marcos, XUEQING XIA, INGRAM, Davis R, DIBRA, Denada, SOMAIAH, Neeta, TORRES, Keila E, RAVI, Vinod

    Published in Cancer research (Chicago, Ill.) (15-03-2014)
    “…To date, no specific marker exists for the detection of circulating tumor cells (CTC) from different types of sarcomas, though tools are available for…”
    Get full text
    Journal Article
  2. 2

    A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53 by Dibra, Denada, Xia, Xueqing, Gagea, Mihai, Lozano, Guillermina, Li, Shulin

    Published in PloS one (01-03-2018)
    “…Spondyloarthropathies, the second most frequently occurring form of chronic inflammatory arthritis, affects young adults in particular. However, a proper model…”
    Get full text
    Journal Article
  3. 3

    Interleukin-30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury by Dibra, Denada, Cutrera, Jeffry, Xia, Xueqing, Kallakury, Bhaskar, Mishra, Lopa, Li, Shulin

    Published in Hepatology (Baltimore, Md.) (01-04-2012)
    “…The liver is the major metabolic organ and is subjected to constant attacks from chronic viral infection, uptake of therapeutic drugs, life behavior…”
    Get full text
    Journal Article
  4. 4

    Discovery of a Linear Peptide for Improving Tumor Targeting of Gene Products and Treatment of Distal Tumors by IL-12 Gene Therapy by Cutrera, Jeffry, Dibra, Denada, Xia, Xueqing, Hasan, Azeem, Reed, Scott, Li, Shulin

    Published in Molecular therapy (01-08-2011)
    “…Like many effective therapeutics, interleukin-12 (IL-12) therapy often causes side effects. Tumor targeted delivery may improve the efficacy and decrease the…”
    Get full text
    Journal Article
  5. 5

    Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo by Dibra, Denada, Mitra, Abhisek, Newman, Melisa, Xia, Xueqing, Cutrera, Jeffry J, Gagea, Mihai, Kleinerman, Eugenie S, Lozano, Guillermina, Li, Shulin

    Published in Clinical cancer research (01-08-2016)
    “…p53 is mutated in about 50% of human cancers, mostly through missense mutations. Expression of mutant p53 is associated with poor clinical outcomes or…”
    Get full text
    Journal Article
  6. 6

    WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells by Dibra, Denada, Cutrera, Jeffry, Xia, Xueqing, Li, Shulin

    Published in PloS one (29-04-2011)
    “…Crosstalk between tumor cells and the cognate microenvironment plays a crucial role in tumor initiation and progression. However, only a few genes are known to…”
    Get full text
    Journal Article
  7. 7

    Expression of WSX1 in Tumors Sensitizes IL-27 Signaling-Independent Natural Killer Cell Surveillance by DIBRA, Denada, CUTRERA, Jeffry J, XUEQING XIA, BIRKENBACH, Mark P, SHULIN LI

    Published in Cancer research (Chicago, Ill.) (01-07-2009)
    “…It is well known that the interleukin (IL)-27 receptor WSX1 is expressed in immune cells and induces an IL-27-dependent immune response. Opposing this…”
    Get full text
    Journal Article
  8. 8

    Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy by Cutrera, Jeffry, Dibra, Denada, Satelli, Arun, Xia, Xuexing, Li, Shulin

    Published in Mediators of Inflammation (01-01-2013)
    “…The safest and most effective cytokine therapies require the favorable accumulation of the cytokine in the tumor environment. While direct treatment into the…”
    Get full text
    Journal Article
  9. 9

    Triple-negative breast tumors are dependent on mutant p53 for growth and survival by Dibra, Denada, Moyer, Sydney M, El-Naggar, Adel K, Qi, Yuan, Su, Xiaoping, Lozano, Guillermina

    “…The tumor suppressor gene is mutated early in the majority of patients with triple-negative breast cancer (TNBC). The most frequent alterations are missense…”
    Get full text
    Journal Article
  10. 10

    FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas by Yan, Jun, Kong, Ling-Yuan, Hu, Jiemiao, Gabrusiewicz, Konrad, Dibra, Denada, Xia, Xueqing, Heimberger, Amy B, Li, Shulin

    “…Fibrinogen-like protein 2 (FGL2) may promote glioblastoma multiforme (GBM) cancer development by inducing multiple immune-suppression mechanisms. The…”
    Get full text
    Journal Article
  11. 11

    Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: An underappreciated symbiotic relationship by Dibra, Denada, Mishra, Lopa, Li, Shulin

    “…Inflammation plays an integral part in tumor initiation. Specifically, patients with colitis, pancreatitis, or hepatitis have an increased susceptibility to…”
    Get full text
    Journal Article
  12. 12

    The cell-to-cell coordination between activated T cells and CpG-stimulated macrophages synergistically induce elevated levels of IL-10 via NF-κB1, STAT3, and CD40/CD154 by Dibra, Denada, Li, Shulin

    Published in Cell communication and signaling (13-12-2013)
    “…Studies into the regulation of interleukin-10 (IL-10), have focused only on the molecular or single-cell level. The cues that induce IL-10 in the context of…”
    Get full text
    Journal Article
  13. 13

    Mutant p53 in concert with an interleukin‐27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice by Dibra, Denada, Xia, Xueqing, Mitra, Abhisek, Cutrera, Jeffry J., Lozano, Guillermina, Li, Shulin

    Published in Hepatology (Baltimore, Md.) (01-03-2016)
    “…The cellular and molecular etiology of unresolved chronic liver inflammation remains obscure. Whereas mutant p53 has gain‐of‐function properties in tumors, the…”
    Get full text
    Journal Article
  14. 14

    A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA.sup.-/- and mutant-p53 by Dibra, Denada, Xia, Xueqing, Gagea, Mihai, Lozano, Guillermina, Li, Shulin

    Published in PloS one (01-03-2018)
    “…Spondyloarthropathies, the second most frequently occurring form of chronic inflammatory arthritis, affects young adults in particular. However, a proper model…”
    Get full text
    Journal Article
  15. 15

    Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30 by Dibra, Denada, Cutrera, Jeffry J, Li, Shulin

    Published in The Journal of immunology (1950) (15-04-2012)
    “…IL-30, the p28 subunit of IL-27, interacts with EBV-induced gene 3 to form IL-27, which modulates both proinflammatory and anti-inflammatory responses during…”
    Get full text
    Journal Article
  16. 16

    p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis by Dibra, Denada, Gagea, Mihai, Qi, Yuan, Chau, Gilda P, Su, Xiaoping, Lozano, Guillermina

    Published in Cancer research communications (29-12-2023)
    “…Obesity is a significant global health concern. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) are common risk factors for…”
    Get full text
    Journal Article
  17. 17

    Abstract 1082: IL27 promotes papilloma formation via inducing a pro-inflammatory milieu in the skin by Dibra, Denada, Xia, Xueqing, Newman, Melissa, Keenan, Camille, Li, Shulin

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Ras activation plays an important role in Squamous Cell Carcinomas (SCC) development. Additionally, there is large evidence confirming the role of inflammation…”
    Get full text
    Journal Article
  18. 18

    Coordination between TLR9 Signaling in Macrophages and CD3 Signaling in T cells Induces Robust Expression of IL301 by Dibra, Denada, Cutrera, Jeffry J., Li, Shulin

    Published in The Journal of immunology (1950) (09-03-2012)
    “…Interleukin 30 (IL30), the p28 subunit of IL27, interacts with Epstein-Barr virus induced gene 3 to form IL27, which modulates both pro- and anti-inflammatory…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo by Dibra, Denada, Xiong, Shunbin, Moyer, Sydney M, El-Naggar, Adel K, Qi, Yuan, Su, Xiaoping, Kong, Elisabeth K, Korkut, Anil, Lozano, Guillermina

    Published in Science advances (16-02-2024)
    “…The tumor suppressor gene is mutated early in most of the patients with triple-negative breast cancer (TNBC). The most frequent alterations are missense…”
    Get full text
    Journal Article